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Abstract
The mechanistic study of inflammatory or autoimmune diseases requires the generation of mouse models that reproduce
the alterations in immune responses observed in patients. Methylated bovine serum albumin (mBSA) has been widely used
to induce antigen-specific inflammation in targeted organs or in combination with single stranded DNA (ssDNA) to generate
anti-nucleic acids antibodies in vivo. However, the mechanism by which this modified protein triggers inflammation is
poorly understood. By analyzing the biochemical properties of mBSA, we found that mBSA exhibits features of an
intermediate of protein misfolding pathway. mBSA readily interact with a list of dyes that have binding specificity towards
amyloid fibrils. Intriguingly, mBSA displayed cytotoxic activity and its binding to ssDNA further enhanced formation of beta-
sheet rich amyloid fibrils. Moreover, mBSA is recognized by the serum amyloid P, a protein unanimously associated with
amyloid plaques in vivo. In macrophages, we observed that mBSA disrupted the lysosomal compartment, signaled along
the NLRP3 inflammasome pathway, and activated caspase 1, which led to the production of IL-1b. In vivo, mBSA triggered
rapid and prominent immune cell infiltration that is dependent on IL-1b induction. Taken together, these data demonstrate
that by mimicking amyloidogenic proteins mBSA exhibits strong innate immune functions and serves as a potent adjuvant.
These findings advance our understanding on the underlying mechanism of how aberrant immune responses lead to
autoimmune reactions.
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Introduction
Antigen-induced arthritis has been widely studied in animals as
a model of rheumatoid arthritis. This chronic inflammation of the
joints can be induced by immunization of animals with an antigen
and intraarticular re-challenge with the same antigen in the
presence of complete Freund’s adjuvant several days later [1].
Methylated bovine serum albumin (mBSA) is by far the most
effective antigen at inducing prolonged inflammation in different
strains of rabbits, mice, and other rodents [2]. The addition of
positive electrical charges by methylation of the anionic native
BSA has been speculated as the determinant factor in the
chronicity of the inflammation induced [3]. In particular, the
cationic mBSA was found retained for a longer time in articular
connective tissues than negatively charged antigens, leading to
a delayed release of antigens and favoring the in situ immune
complex formation and deposition [3].
Interestingly, mBSA has also been used as a carrier protein for
the induction of anti-DNA antibodies in other autoimmune
disease models [4–9]. DNA is poorly immunogenic by itself and
immunization of mice with nucleic acids fails to induce detectable
anti-DNA titers. However, mice receiving denatured single
stranded DNA from different sources complexed to mBSA
develop anti-DNA antibodies approximating the serology ob-
served in systemic lupus erythematosus (SLE) patients [4,10]. In
these models, it was thought that the increased adjuvancy of
mBSA is responsible for breaking tolerance to nucleic acids, yet
the precise mechanism by which it is achieved is unknown.
Nevertheless, mBSA was included as a carrier protein to obtain
high titer antibodies in other studies [11,12].
Adjuvants are substances that are included in vaccines to
critically enhance the magnitude and modulate the quality of the
protective immune responses. Not until recently, the mechanism
how adjuvants fulfill such function has been revealed. Among
different types of adjuvants used in clinics or in experimental
animals, they universally show strong capacity to trigger in-
flammation and activate different aspects of the innate immune
system, which prime the adaptive immune system to induce
antibody or cellular responses. In particular, the oil-based
aluminum adjuvant has been shown to exert a direct effect on
inflammasome action and IL-1b production, a key mediator of
inflammation. The application of adjuvants and their principle of
action are not limited to vaccines to prevent infectious diseases, but
are increasingly tested in cancer immunotherapy, where anti-
tumor specific response is intentionally induced.
Amyloid fibrils are stable insoluble aggregates of terminal
misfolded protein products with extensive beta sheet structures
[13–15]. These misfolded particulates participate in inflammatory
responses in both central nervous system and peripheral organs,
mainly by activating inflammasome and inducing IL-1b secretion
[16–19]. Recently we observed that the precursor form of amyloid,
soluble protein oligomers, can efficiently bind DNA converting
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them into amyloids [20]. Strikingly, these nucleic acid-containing
amyloids could initiate inflammation and their injection to non-
autoimmune mice lead to a broad anti-autoantigen response with
the generation of anti-DNA autoantibodies [21].
Here we show that mBSA shares properties with both
oligomeric amyloid precursors and fibrous amyloid. mBSA is able
to activate the inflammasome in macrophages and induce
profound immune cell infiltration in vivo. Thus the amyloidogenic
properties of mBSA render it capable to initiate inflammation and
may explain the adjuvant effect observed in vivo.
Materials and Methods
Reagents
Bovine serum albumin (BSA), mBSA and thioglycollate medium
were purchased from Sigma. Amyloidogenic peptides were
obtained commercially: Ab (1–42) from EMD Biosciences and
reverse Ab peptide from California Peptide Research.
Binding with Amyloid-specific Dyes
The assays were performed as described previously [20]. Briefly,
BSA samples (0.5 mg/ml) were mixed with 50 mM of Thioflavin T
(Sigma-Aldrich) and measured for fluorescence emission in
a spectrofluorometer (Jasco FP-6500) with an excitation wave-
length of 450 nm and an emission between 450–600 nm. Proteins
were also mixed with 5 mM of 4,4-dianilino-1,1-binaphthyl-5,5-
disulfonic acid dipotassium salt (bis-ANS; Sigma-Aldrich). The
fluorescence was measured in spectrofluorometer with an excita-
tion wavelength of 395 nm and an emission between 420 and
580 nm. Alternatively, BSA samples (50 mg/ml) were pre-mixed
with denatured salmon sperm ssDNA (50 mg/ml) for 2 hours at
room temperature. After incubating with Congo Red (30 mg/ml)
for 30 min, the fluorescence was measured in a spectrofluorometer
with an excitation wavelength of 497 nm and an emission between
600 and 700 nm. For microscopic analysis, BSA samples (500 mg/
ml) were first mixed with denatured salmon sperm ssDNA
(500 mg/ml) for 2 hours at room temperature. Samples were then
deposited in wells of a positive charged Teflon printed slide, 8 well
6 mm diameter (Electron Microscopy Sciences) and air dried.
Samples were fixed in 4% paraformaldehyde, washed in water and
stained with 1% Thioflavin S or 1% Congo Red in 80% Ethanol,
100 mM NaOH. Slide was washed in 80% Ethanol, air dried, and
analyzed microscopically in bright and polarized light using
Olympus BX41 microscope.
Transmission Electron Microscopy Analysis
Samples were placed on 400 mesh carbon coated, formvar
coated nickel grids treated with poly-l-lysine for 1 hour. Excess
samples were blotted with filter paper, then stained with filtered
aqueous 2% uranyl acetate for 2 mins. Stain was blotted dry from
the grids with filter paper and samples were allowed to dry.
Samples were then examined in a JEM 1010 transmission electron
microscope (JEOL, USA, Inc., Peabody, MA) at an accelerating
voltage of 80 Kv. Digital images were obtained using the AMT
Imaging System (Advanced Microscopy Techniques Corp.,
Danvers, MA).
Nucleic Acid-binding Gel Shift Assay
Different proteins were incubated with 0.5 mg of denatured
salmon sperm ssDNA in TE buffer (10 mM Tris-Cl, pH 7.4 and
1 mM EDTA) for 60 min. The samples were then loaded onto 1%
agarose gel and subjected to electrophoresis separation. For
inhibition with glycosaminoglycan, BSA proteins were pre-
incubated with different amounts of heparin for 15 min prior to
mixing with DNA.
Binding of SAP to mBSA
Different concentrations of Ab peptide (1-42), Ab (42-1), mBSA
or mBSA+ssDNA in carbonate buffer were coated in ELISA plates
overnight at 4uC. The plates were blocked with buffer containing
150 mM NaCl, 25 mM Tris, 1% BSA, 2 mM CaCl2 for 1 hour at
room temperature. After several washes, biotinylated human SAP
(Calbiochem) (4 mg/ml) was added for 2 hours. Then, streptavi-
din-HRP was added for 1 hour and TMB used as the substrate.
Absorbance at 450 nm was read using a spectrophotometer
SpectraMax M5e (Molecular Devices).
Cytotoxicity
Proteins were incubated with RPMI 8226 (16106/ml) at
different concentrations in culture medium at 37uC for 24 hrs.
Cells were washed, resuspended in propidium iodide containing
buffer (BD Bioscience) and analyzed on a FACSCaliburTM cyt-
ometer (BD Bioscience). In some experiments, proteins were
mixed with ssDNA or heparin at 1:1 ratio 30 min prior to adding
to the cells.
Preparation and Stimulation Bone-marrow Derived
Macrophages
Bone marrows of 8- to 12-wk-old Balb/c mice were harvested
and cells were cultured in RPMI medium +10% FBS supplemen-
ted by 20% L929 supernatants for 5 days to differentiate
macrophages. BMDMs at 56105 cells/ml were primed with
10 ng/ml LPS for 4 hours then stimulated with 5 mg/ml BSA/
mBSA 65 mg/ml ssDNA or 10 mM Ab/reverse peptides for 2
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hours. Supernatants were collected to measure IL-1b secretion by
ELISA. In some experiments, LPS-primed cells were pre-in-
cubated with 10 mg/ml Cytochalasin B, 50 mM KCL, 25 mg/ml
Glybenclamide or 50 mM Ac-YVAD-CMK 15 min before stim-
ulation. To analyze lysosomes integrity, BMDM cells were stained
with 1 mg/ml acridine orange and then stimulated as previously
for 3 hours. For the caspase 1 analysis, stimulated cells were
stained with the FAM-YVAD-FMK FLICATM Caspase 1 reagents
(Immunchemistry Tech.) according to the manufacturer’s pro-
tocol.
Mice and Injections
Wild-type BALB/cByJ mice were obtained from The Jackson
Laboratory. All experiments with mice were performed in
compliance with the principles and procedures outlined in the
NIH Guide for the Care and Use of Animals and were approved
by The University of Texas MD Anderson Cancer Center Animal
Care and Use Committee. To evaluate innate immune response,
the 8- to 12-wk-old Balb/c mice received i.p. 30 mg of endotoxin-
free denatured ssDNA (Invivogen) together with 75 mg of BSA or
mBSA in 200 ml PBS or 1 ml of 3% TG. In other experiments, 8-
to 12-wk-old C57BL/6J (The Jackson Laboratory) and IL-1b2/2
mice (kindly provided by Dr. Yoichiro Iwakura) were used. Female
and male mice were equally divided among the test groups and
analyzed.
Analysis of Peritoneal Inflammation
Peritoneal exudate cells were harvested at 4 hours after injection
of stimuli. FACS analysis was performed with fluorophore-
conjugated Ab against F4/80 (Biolegend), Ly6C, Ly6G (Miltenyi),
and CD11b (BD Bioscience) then analyzed on an LSR II.
Countbright absolute counting beads (Molecular Probes) were
used to calculate cell numbers. Cell populations were qualified as
CD11b+ Ly6C+ F4/80high macrophages, CD11b+ Ly6G2 Ly6C+
monocytes and CD11b+ Ly6C2 Ly6G+ neutrophils. Quantitative
PCR analysis on peritoneal exudate cells were performed with the
primers listed in Table 1.
Statistical Analysis
Statistical analyses were performed with the two-tailed unpaired
Student t-test or with a two-way ANOVA test with Bonferroni
post-test using GraphPad Prism 5.0 software. P.0.05 was
considered nonsignificant.
Results
mBSA Exhibits Biochemical Features Related to Amyloids
Amyloids are insoluble fibrous protein aggregates that display
a cross-beta sheet quaternary structure that can be recognized by
planar aromatic dyes like Thioflavin or Congo Red [22,23].
Surprisingly, dye Thioflavin T showed an increased fluorescence
emission in the presence of mBSA but not in the presence of the
native BSA, suggesting that the methylation of the protein led to
the formation of beta sheet rich structures (Fig. 1A). Nucleic acids
are negatively charged molecules, and bind efficiently to cationic
groups. Whereas native BSA does not bind to denatured ssDNA,
mBSA can form complexes with ssDNA in a dose dependent
manner (Fig. 1B). We then wondered whether such interaction
would change the biochemical properties of mBSA. Since
Thioflavin T reacts with nucleic acids [24], we used a closely
related dye Thioflavin S, which also emitted fluorescence upon
binding to mBSA (Fig. 1C). Interestingly, mBSA mixed with
ssDNA resulted in highly aggregated complexes that are positive
with Thioflavin S (Fig. 1C).
In contrast to native BSA, mBSA has limited solubility in water
and frequently precipitates on slides, suggesting methylation has
tremendous impact on the biophysical property of the protein. To
further analyze the beta sheet content in mBSA, we tested Congo
red, a dye specific for amyloid [22,23]. Whereas no fluorescence of
the dye could be observed in the presence of BSA or BSA plus
ssDNA, the Congo red fluorescence was highly detectable from
mBSA (Fig. 1D). Furthermore, binding with ssDNA significantly
enhanced Congo red emission. When observed under polarized
light, Congo red staining on mBSA emitted yellow-orange glow,
whereas mBSA+ssDNA complexes gave an apple-green birefrin-
gence, characteristic of amyloid containing cross-beta sheets
(Fig. 1E). To further confirm this finding, we analyzed the samples
by transmission electron microscopy and detected fibrous
structures highly abundant within the mBSA+ssDNA complexes
(Fig. 1F). mBSA, in contrast to native BSA, formed non-fibrous
particulates under the same condition. Therefore through
complexing with DNA, mBSA displays classic characteristics of
beta sheet rich amyloid.
mBSA Display Properties of Protein Misfolding
Intermediate
The formation of insoluble amyloid requires the generation of
soluble oligomeric proteins, which are precursors of amyloids with
unusual cytotoxicity [25,26]. We previously demonstrated that
binding with nucleic acids or glycosaminoglycans converts soluble
protein oligomers into insoluble inert amyloids [20]. Having
observed that mBSA interacts with DNA and gains enhanced
Congo red fluorescence made us hypothesize that mBSA may
share certain features with amyloid precursors. Analogous to
stabilized protein oligomer [20], binding of mBSA to DNA was
inhibited by the presence of increasing concentration of heparin,
a prototypical glycosaminoglycan (Fig. 2A). Soluble protein
oligomers, but not the insoluble amyloid fibrils, have the capacity
to disrupt the lipid bilayer of cell membranes to cause cell death
[27]. Interestingly, mBSA, but not BSA, displayed cytotoxicity
towards a human plasmacytoma line RPMI 8226 cells in a dose
dependent manner (Fig. 2B). Similar to stabilized protein oligomer
[20], such cytotoxicity could be abolished in the presence of
ssDNA or heparin (Fig. 2C).
To understand the molecular basis of such intriguing cellular
effect, we examined further the biochemical properties of mBSA.
As an intermediate of protein misfolding, soluble protein oligomers
display structural alteration that is distinct from the native form of
the proteins [28,29]. mBSA, but not the native form, gave rise to
prominent fluorescent emission profiles with 4,4-bis (1-anilino-
naphthalene 8-sulfonate) (bis-ANS) (Fig. 2D), a fluorescent dye
preferentially binds to hydrophobic areas of a protein structure
Figure 1. mBSA displays features of amyloid. (A) Fluorescence intensity of Thioflavin T at 480 nm in buffer, with BSA, mBSA, Ab or with the
reverse control peptide. Error bars are means6 SD of 3 independent experiments. **p,0.005. (B) Gel shift analysis of salmon sperm ssDNA pre-mixed
with different amounts of BSA or mBSA. (C) Thioflavin S fluorescence in the presence of different BSA proteins or aggregates observed under
fluorescence microscopy. Original magnification 100X. scale bar: 20 mm. (D) Fluorescence emission profiles of Congo Red in the presence of buffer,
different proteins or aggregates. (E) Birefringence of Congo Red on mBSA or mBSA plus ssDNA aggregate observed by polarized light microscopy.
Original magnification 40X. bar: 50 mm. (F) Transmission electron microscopy analysis of mBSA or mBSA plus ssDNA. Bar: 100 nm.
doi:10.1371/journal.pone.0063214.g001
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Figure 2. mBSA shares properties with soluble amyloid precursor. (A) Gel shift analysis of salmon sperm ssDNA that was pre-mixed with
mBSA in the presence of different amounts of heparin. (B) Assessment of cell death of RPMI 8226 cells cultured 24 hrs with different amounts of BSA
or mBSA. Shown are representative results of PI staining from 2 independent experiments. (C) Assessment of dead RPMI 8226 cell population cultured
with different amounts of BSA or mBSA that were pre-incubated with medium, DNA or heparin. Results shown are representative of 2 independent
experiments. (D) Fluorescence emission profiles of bis-ANS obtained after incubation in PBS, with BSA or with mBSA.
doi:10.1371/journal.pone.0063214.g002
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[30]. This indicates the presence of exposed hydrophobic regions
that are normally buried in natively folded structures, consistent
with previous reports on soluble protein oligomers [20,28,29].
Serum amyloid P (SAP) is a member of pentraxins that
specifically associates with beta sheet rich amyloid fibrils [31–33].
In vitro, SAP binds to amyloidogenic Amyloid b (Ab) peptide, but
not to a control peptide with reversed sequence (Fig. 3A).
Interestingly, SAP positively recognizes both mBSA and
mBSA+ssDNA, but not BSA nor DNA, in a similar dose-
dependent manner (Fig. 3B). Altogether, these results suggest that
mBSA represents an intermediate of protein misfolding pathway
that can lead to the formation of amyloid.
mBSA Triggers IL-1b Production by Activating
Inflammasome
It has been demonstrated that amyloidogenic peptides Ab can
activate the NLRP3 inflammasome in bone marrow-derived
macrophages (BMDMs), which leads to the production of IL-1b
[17,19]. In addition, oligomers of islet amyloid polypeptide (IAPP)
were shown to similarly activate NLRP3 inflammasome [18]. We
then assessed the capacity of mBSA and mBSA+ssDNA to
similarly stimulate BMDMs. First of all, neither of them directly
induced pro-IL-1b or IL-1b expression in BMDMs. As TLR/NF-
kB pathway is potent at inducing pro-IL-1b expression, inflam-
masome activation then leads to maturation and release of IL-1b.
Interestingly, both mBSA and mBSA+ssDNA induced LPS-
primed BMDMs to secrete IL-1b to a similar extend as Ab
peptides (Fig. 4A). None of the control proteins, BSA or the
reverse peptides of Ab, induced significant IL-1b. To further
dissect the mechanism by which the production of IL-1b was
reached, we stained the stimulated cells with the fluorescent probe
FAM-YVAD-FMK to label the active caspase 1, an enzyme that
processes IL-1b maturation. As expected, BMDMs only when
stimulated by mBSA or mBSA+ssDNA had increased fluorescence
in their cytoplasm, suggesting that caspase 1 was activated by these
stimuli (Fig. 4B).
Initiation of the inflammasome complex formation in macro-
phages largely depends on the activation of Cathepsin B following
phagosomal destabilization [19,34]. The integrity of the lysosomal
compartment in cells can be verified by staining the cells with the
acridine orange, a dye that accumulates in lysosomes. Strikingly,
macrophages exposed to mBSA and mBSA+ssDNA showed
a significantly decreased acridine orange staining compared to
cells cultured with BSA controls, suggesting that both mBSA and
mBSA+ssDNA triggered lysosomal disruption in macrophages
(Fig. 4C). It is also known that activation of the inflammasome
requires endocytosis of particulates and the induction of potassium
efflux. In the presence of the endocytosis inhibitor cytochalasin B
or increasing concentration of KCL, the IL-1b released by mBSA-
stimulated BMDMs was drastically abolished, similarly to their
effects on inflammasome activator ATP (Fig. 4D).
Since both Ab and IAPP activate NLRP3 inflammasome to
prompt IL-1b maturation [16,19], we further examined the role of
this signaling pathway in mediating mBSA-induced IL-1b. Similar
to Ab, both mBSA and mBSA+ssDNA are sensitive to the pre-
treatment of glybenclamide, an inhibitor acts downstream of the
P2X7 receptor but upsteam of NLRP3 [35], on BMDM when
stimulating IL-1b release (Fig. 4E). Following the assembly of the
NLRP3 inflammasome, caspase 1 is activated by autocatalytic
processing that triggers the maturation of IL-1b and its release. As
expected, the secretion of IL-1b induced by mBSA is abolished in
the presence of the caspase 1 inhibitor Ac-YVAD-CMK (Fig. 4F).
These results collectively demonstrate that mBSA is able to induce
IL-1b secretion by likely signaling through the NLRP3 inflamma-
some pathway and activating caspase 1 complexes in macro-
phages.
mBSA Elicits IL-1b-dependent Inflammation in vivo
Stimulation of the inflammasome and release of IL-1b can be
the initial steps in an inflammatory cascade, an important property
of many adjuvants [36]. To demonstrate the innate immune
function of mBSA, we injected mice intraperitoneally with BSA,
mBSA or thioglycollate medium (TG). In comparison, we also
inoculated endotoxin-free ssDNA together with either BSA or
mBSA. Leukocytes infiltrating the peritoneal cavity 4 hours
following injection were analyzed by FACS. Interestingly, mBSA
induced significant recruitment of cells, especially with increased
numbers of neutrophils and macrophages (Fig. 5A). Remarkably,
mBSA plus ssDNA triggered the most abundant leukocyte
infiltration, more than what induced by TG, a stimulatory agent
routinely used to induce peritoneal inflammation for elicitation of
macrophages.
Consistent with the result of BMDM stimulation, both mBSA
and mBSA+ssDNA induced IL-1b secretion which was detectable
Figure 3. Serum amyloid P binds to mBSA. (A) Binding of SAP to
different amounts of Ab or the reverse control peptide was assessed by
ELISA. Similar results were obtained from 2 independent experiments.
(B) Binding of SAP to different amounts of BSA or mBSA with or without
ssDNA was assessed by ELISA. Error bars are means 6 SD of 2
independent experiments.
doi:10.1371/journal.pone.0063214.g003
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from the peritoneal fluid (Fig. 5B). Secretion of IL-1a, a closely
related cytokine that shares the receptor with IL-1b, was also
prompted by mBSA, mBSA+ssDNA and TG, the stimuli that
triggered peritoneal inflammation. Of note, mBSA was more
potent at inducing IL-1a/b than mBSA+ssDNA or TG. Further
analysis of the gene expression of the peritoneal exudate cells
revealed that the transcripts of IL-1 family cytokines, including IL-
1a, IL-1b and IL-18, were largely upregulated after inoculation of
mBSA, mBSA+ssDNA and TG (Fig. 5C). Interestingly,
mBSA+ssDNA selectively augmented the transcription of cytokine
IFNc. In addition, transcripts encoding chemokines, such as
CCL5, CCL11, CCL12, CXCL1, CXCL9, CXCL11 and
CXCL12, were all upregulated by mBSA, mBSA+ssDNA and
TG. Opposite of weaker IL-1a/b induction, mBSA+ssDNA
injection led to a significantly higher expression of this group of
chemokines over mBSA (Fig. 5D).
To assess the role of IL-1b in mBSA and mBSA+ssDNA
induced inflammation, we inoculated these molecules and
corresponding controls in wild type or IL-1b2/2 mice i.p.
Interestingly, IL-1b deficiency significantly abolished the perito-
nitis induced by mBSA and mBSA+ssDNA (Fig. 5E). Thus, mBSA
and its derived molecular complex can potently trigger in-
flammation via induction of IL-1b as a result of inflammasome
activation.
Discussion
In recent years, aberrantly folded proteins in the form of
amyloid fibrils and misfolded protein aggregates have been
recognized as a special class of danger signals that trigger
inflammation via inflammasome activation to exacerbate diverse
human diseases, such as Alzheimer’s disease and type 2 diabetes
[18,19,37,38]. The present study describes the biochemical and
cellular mechanism underlying the unexpected innate immune
function of mBSA, a modified BSA protein used in various in vivo
disease models. In addition to altered charges, methylation
significantly affects the folding of BSA molecule and generates
an intermediate of protein misfolding pathway that allows the
formation of amyloid. We have shown that a complex containing
mBSA and ssDNA display characteristics of beta sheet rich
amyloid. Consistent with previous reports on natural amyloids,
mBSA and mBSA+ssDNA signal along the NLRP3 inflammasome
pathway and induce maturation of IL-1b. In addition, these agents
are potent to trigger IL-1b-dependent peritoneal inflammation
when inoculated in vivo.
Our study strongly suggests that mBSA is not a normal protein
antigen that triggers regular memory immune response when
injected to tissues. It rather acts as a self-adjuvanted antigen to
induce profound local inflammation while presenting the antigenic
backbone. The capacity of mBSA to induce a sustained organ-
specific inflammation has been thought to depend on its cationic
property which delays its release in vivo. Yet, cationization of
proteins is not sufficient per se to elicit an inflammatory response,
since intra-articular injection of cationic myoglobulin or lysozyme
had no effect [39]. Our results indicate that mBSA may contribute
to local tissue inflammation at least partly by direct induction of
IL-1 family cytokine production via inflammasome activation. In
fact, Verri et al, reported the significant amount of IL-1b induced
by mBSA in cutaneous and articular hypernociception and
effective inhibition of hypernociception by treatment with IL-1ra
[40]. Displaying properties of soluble protein oligomers, mBSA
may also preferentially deposit onto the proteoglycans present in
the extracellular matrix of the tissue for prolonged retention; and/
or exert cytotoxic effect on surrounding cells to release cellular
content and trigger further inflammation.
In several pioneering studies, mBSA has been used as
a designated carrier protein for DNA to immunize mice in order
to induce anti-DNA antibodies [5–9]. It was recognized that the
presence of this immunogenic carrier protein was a prerequisite
for eliciting an immune response toward denatured DNA, as DNA
is non-immunogenic [7]. Our data clearly show that mBSA
directly binds to ssDNA, which prompts further conversion to
amyloid, and the resulting mBSA-ssDNA complex elicits profound
peritoneal inflammation in vivo.
Recently, we have shown that immunization of amyloid fibrils
containing DNA can trigger non-autoimmune mice to develop
lupus-like syndrome, including anti-DNA and anti-RNA and other
autoantibodies [21]. The current molecular link between mBSA
and amyloid-related proteins invites a closer look at the cellular
and immunological functions of different misfolded protein
species. While mBSA preferentially binds to denatured ssDNA,
stabilized amyloid precursor protein we studied interacts readily
with ssDNA and all natural nucleic acids including double-
stranded DNA (dsDNA) and RNA. By dose titration, the cytotoxic
activity of mBSA is rather repressed in comparison with stabilized
amyloid precursor [20]. Inoculated together with DNA, both
mBSA and stabilized amyloid precursor induced robust peritoneal
infiltration in vivo. However, we were unable to detect the
expression of type I interferon (IFN-I) after mBSA challenge (data
not shown), whereas DNA-containing amyloid induced significant
IFNa/b and interferon-inducible gene expression [21]. This is
consistent with the result obtained with human primary pDCs:
mBSA complexed with natural nucleic acids failed to induce
IFNa/b (data not shown), a drastic contrast to nucleic acid-
containing amyloid [21]. The consequence of lacking IFN-I may
correlate with the limited antibody crossreactivity with autoanti-
gens after mBSA-dsDNA immunization [4]. In contrary, DNA-
containing amyloid provoked broad anti-self-antigen responses
beyond the specific reactions to the immunogen, suggesting an
essential role of type I interferon in autoimmunity.
By instigating strong inflammatory response, adjuvants are
critical components of effective vaccine immunization. The finding
that a seemingly simple protein mBSA may in fact act as an
unintended adjuvant to induce various autoimmune or autoin-
flammatory disorders is intriguing. The current understanding
about how immune tolerance is broken by environmental,
exogenous or self-derived triggering factors remains incomplete.
There are increasing evidence to suggest a potential association of
Figure 4. mBSA elicits IL-1b production by activating inflammasome. (A) Secretion of IL-1b by BMDM stimulated with different forms of BSA
or Ab peptides for 2 hours. Error bars are means 6 SD of 5 independent experiments. ****p,0.0001. (B) Caspase 1 activation in BMDMs stimulated
with different forms of BSA analyzed by FLICA assay. Representative result of 3 independent experiments is shown. Original magnification 100X. bar:
20 mm. (C) Acridine orange staining of BMDM stimulated by different forms of BSA to reveal lysosome integrity. Original magnification of fluorescence
microscopy 100X. bar: 20 mm. (D) Secretion of IL-1b by BMDM induced by different forms of BSA in the presence of different inhibitors. Error bars are
means6 SD of 2 independent experiments. *p,0.05, **p,0.005. (E) Secretion of IL-1b by BMDM induced by different forms of BSA or Ab peptides in
the presence or not of the NRLP3 inhibitor glybenclamide. Error bars are means 6 SD of data obtained with cells from 4 different mice. *p,0.05,
**p,0.005. (F) Secretion of IL-1b by BMDM induced by different forms of BSA in the presence of the caspase 1 inhibitor Ac-YVAD-CMK. Error bars are
means 6 SD of data obtained with cells from 3 different mice. *p,0.05, **p,0.005.
doi:10.1371/journal.pone.0063214.g004
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vaccination and/or immunostimulatory adjuvants with autoim-
mune abnormalities. For instance, administration of tetanus toxoid
vaccine may trigger antibodies targeting beta2-GPI, inducing
Autoimmune/Autoinflammatory Syndrome Induced by Adju-
vants (ASIA) [41,42]. Injection of hydrocarbon oils such as
pristane can cause chronic inflammation and induce systemic
autoimmunity in non-lupus prone mice [43]. Therefore, the
mechanism how molecules with strong adjuvant functions facilitate
the development of autoimmunity deserves further in-depth
investigation.
In conclusion, we have revealed an innate stimulatory adjuvant-
like propensity of mBSA, which stems from its unique amyloid-like
biochemical characteristics. This finding helps fully understand
and properly interpret the phenotypes observed in different animal
models.
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Figure 5. mBSA triggers inflammation in vivo. (A) Numbers of infiltrating macrophages (left), monocytes (middle) and neutrophils (right) in the
peritoneum of mice 4 h after i.p. injection of different stimuli. Error bars are means 6 SD of 4 mice per group. *p,0.05, **p,0.005. (B) Levels of IL-1a
(left) and IL-1b (right) secreted in the peritoneal lavages. *p,0.05. (C) Gene expression of peritoneal exudate cells presented as a heat map. One BSA-
injected animal was used as a reference. Each block represents one mouse. (D) Plot of induced transcript expression of the chemokines from the
bottom cluster of *p,0.05, **p,0.005. (C). (E) Numbers of infiltrating macrophages (left), monocytes (middle) and neutrophils (right) in the
peritoneum of wild-type or IL-1b2/2 mice 4 h after i.p. injection of different stimuli. Error bars are means 6 SD of 3 mice per group. **p,0.005.
doi:10.1371/journal.pone.0063214.g005
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